These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 547038)

  • 1. Improvement of the calcitonin radioimmunoassay.
    Wood WG; Müller OA; Stalla G; Scriba PC
    J Clin Chem Clin Biochem; 1979 Dec; 17(12):781-7. PubMed ID: 547038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
    Becker KL; Snider RH; Silva OL; Moore CF
    Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma.
    Samaan NA; Castillo S; Schultz PN; Khalil KG; Johnston DA
    J Clin Endocrinol Metab; 1980 Aug; 51(2):237-41. PubMed ID: 6249833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum calcitonin in thyroid disorders and in pheochromocytoma kindred.
    Hornicek FJ; Danowski TS; Robinson SM; Sweeney KT; Malinin GI
    Ann Clin Lab Sci; 1986; 16(2):103-7. PubMed ID: 3963731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay for human calcitonin employing synthetic calcitonin M: its clinical application.
    Morita R; Fukunaga M; Yamamoto I; Mori T; Torizuka K
    Endocrinol Jpn; 1975 Oct; 22(5):419-26. PubMed ID: 1061670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum calcitonin in medullary thyroid carcinoma. Radioimmunoassay technique and diagnostic value.
    Almqvist S; Telenius-Berg M; Wästhed B
    Acta Med Scand; 1974 Sep; 196(3):177-80. PubMed ID: 4472910
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
    Myhre L; Gautvik KM
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of new assays for determination of serum calcitonin concentrations.
    Weissel M; Kainz H; Tyl E; Ogunyemi E; Woloszczuk W
    Acta Endocrinol (Copenh); 1991 May; 124(5):540-4. PubMed ID: 2028712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay of calcitonin in unextracted human serum: a sensitive method.
    Emmertsen K; Marqversen J; Jensen FT; Hansen HH
    Scand J Clin Lab Invest; 1982 Nov; 42(7):539-44. PubMed ID: 6186008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine calcitonin levels in patients with bronchogenic carcinoma.
    Becker KL; Nash DR; Silva OL; Snider RH; Moore CF
    JAMA; 1980 Feb; 243(7):670-2. PubMed ID: 6243372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
    Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
    Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spuriously elevated plasma calcitonin in a patient with a thyroid nodule not associated with medullary thyroid carcinoma.
    Lamb EJ; Heddle RM; Ellis A
    Postgrad Med J; 1999 May; 75(883):289-90. PubMed ID: 10533634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interlaboratory comparison of radioimmunological calcitonin determination.
    Raue F
    J Clin Chem Clin Biochem; 1982 Mar; 20(3):157-61. PubMed ID: 7077230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDN-21: possible tumor marker for medullary thyroid carcinoma.
    Takami H; Shikata J; Horie H; Sekine K; Ito K
    J Surg Oncol; 1990 Aug; 44(4):205-7. PubMed ID: 2385096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
    Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioimmunoassay of plasma calcitonin gene-related peptide (CGRP) levels in patients with endocrine tumor].
    Takami H; Shikata J; Horie H; Horiuchi J; Sakurai H; Ito K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2219-25. PubMed ID: 2786708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
    Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
    Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
    Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
    Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests.
    Gharib H; Kao PC; Heath H
    Mayo Clin Proc; 1987 May; 62(5):373-8. PubMed ID: 3573825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The setting up of human serum calcitonin radioimmunoassay and its clinical application].
    Zhan Z; Meng X; Chen L; Zhou X; Liu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Jun; 19(3):236-40. PubMed ID: 10453498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.